Spyre Therapeutics
SYRE
#4826
Rank
$1.50 B
Marketcap
$29.20
Share price
-6.62%
Change (1 day)
170.12%
Change (1 year)

Revenue for Spyre Therapeutics (SYRE)

Revenue in 2024 (TTM): N/A

In 2023 the company made a revenue of $0.88 Million USD a decrease over the revenue in the year 2022 that were of $2.32 Million USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Spyre Therapeutics from 2014 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) N/A-100%
2023 $0.88 M-61.96%
2022 $2.32 M-87.57%
2021 $18.73 M
2020 N/A
2019 N/A-100%
2018 $3.88 M-25.29%
2017 $5.2 M12.45%
2016 $4.62 M-23.94%
2015 $6.08 M
2014 N/A